Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-12-01
1997-12-09
Lilling, Herbert J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 13, 514 14, 514 15, 514 16, 514 17, 514 18, A61K 3816, A61K 3808, A61K 3810
Patent
active
056960875
ABSTRACT:
Compositions including all or a portion and chemically or recombinantly synthesized analogues of the carboxy terminal region of bile salt-activated lipase (BAL) are described, which, when orally ingested, compete with native BAL in binding to the intestinal surface and thus reduce the amount of cholesterol taken into the blood stream.
REFERENCES:
patent: Re33885 (1992-04-01), Mattson
patent: 4602003 (1986-07-01), Maginow
patent: 4944944 (1990-07-01), Tang et al.
patent: 4976968 (1990-12-01), Steiner
patent: 5017565 (1991-05-01), Lange, III et al.
patent: 5063210 (1991-11-01), Lange, III et al.
patent: 5173408 (1992-12-01), Lange, III et al.
patent: 5200183 (1993-04-01), Tang et al.
patent: 5376640 (1994-12-01), Miyazaki et al.
patent: 5519001 (1996-05-01), Kushwaha et al.
Nilsson et al "Eur. J. Biochem" vol. 192 pp. 543-550 (1990).
Baba et al "Biochem" 1991 vol. 30 pp. 500-510.
Wang and Johnson, "Purification of Human Milk Bile Salt-Acticated Lipase," Anal. Biochem. 133:457-461 (1983).
Wang, C.-S., "Human Milk Bile Salt-activated Lipase", J. Biol. Chem. 256:10198-10202 (1981).
Wang, "Acyl-chain specificity of human milk bile-salt-activated lipase," Biochem. J. 279:297-302 (1991).
Wang, C.-S., and R.L. Smith, "Lowry Determination of Protein in the Presence of Triton X-100", Anal. Biochem. 63:414-417 (1975).
Wang, et al., "Bile Salt-Activated Lipase Mediates Cholesterol Absorption by Binding of its Mucin-Like Region to Intestinal Surface," Science (1995)*.
Wang, et al., "Bile-salt-activated lipase: effect on kitten growth rate," Am. J. Clin. Nutr. 49:457-463 (1989).
Wang, "Purification of Carboxyl Ester Lipase from Human Pancrease and the Amino Acid Sequence of the N-Terminal Region," Biochem. and Biophys. Res. Comm. 155:950 (1988).
Westphal, H., "Transgenic mammals and biotechnology," FASEB J. 3:117-120 (1989).
"CV Therapeutics Begins Phase I Trial on Cholesterol-Reduction Agent," Biotech. Bulletin p. 11 (1994).
Lopez-Candales, et al., "Cholesterol Transport Function of Pancreatic Cholesterol Esterase: Directed Sterol Uptake and Esterification in Enterocytes," Biochem. 32:12085-12089 (1993).
Lowry, O.H., et al., "Protein Measurement with the Folin Phenol Reagent," J. Biol. Chem. 193:265 (1951).
Luckow, V.A. and Summers, M.D., "Trends in the Development of Baculovirus Expression Vectors", Bio/Technology 6:47 (1988).
McKean, et al., "Effects of Inhibitors of Pancreatic Cholesterol Ester Hydrolase (PCEH) On .sup.14 C-cholesterol Absorption in Animal Models," FASEB Journal 6(4):PA1388 (1992).
Nilsson, J., et al., "cDNA cloning of human-milk bile-salt-stimulated lipase and evidence for its identity to pancreatic carboxylic ester hydrolase," Eur. J. Biochem. 192:543-550 (1990).
Nilsson-Ehle, P., and M.C. Schotz, J. Lipid Res. 17:536-541 (1976)*.
Poorman, et al., "Isolation and Characterization of Native Human Renin Derived from Chinese Hamster Ovary Cells," Proteins 1:139-145 (1986).
Reue, K., et al., "cDNA cloning of carboxyl ester lipase from human pancrease reveals a unique proline-rich repeat unit," J. Lipid Res. 32:267-276 (1991).
Rudd, Edwin A., "Pancreatic carboxyl ester," Lipases (Elsevier, publishers, 1984).
Scahill, S.J., et al., "Expression and characterization of the product of a human immune interferon cDNA gene in Chinese hamster ovary cells," Proc. Natl. Acad. Sci., U.S.A. 80:4654-4658 (1983).
Segel, I.H., "Enzyme Activation," Enzyme Kinetics 227-231, John Wiley & Sons, New York (1975).
Studier, F.W. et al., "Use of T7 RNA Polymerase to Direct Expression of Cloned Genes," Methods Enzymol. 185:60-89 (1990).
Wang, et al., "Kinetics of Acylglycerol Sequential Hydrolysis by Human Milk Bile Salt Activated Lipase and Effect of Taurocholate as Fatty Acid Acceptor," Biochem. 27:4834 (1988).
Wang & Kloer, "Kinetic Properties of Human Pancreatic Carboxylesterase," Biochim. et Biophys. Acta 754:142-149 (1983).
Wang, C.-S., and J.A. Hartsuck, "Bile salt-activated lipase. A multiple function lipolytic enzyme," Biochim. Biophys. Acta 1166:1-19 (1993).
Freed, et al., "Bile salt-stimulated lipase in non-primate milk: longitudinal variation and lipase characteristics in cat and dog milk," Biochim. and Biophy. Acta 878:209-215 (1986).
Gallo, et al., "Inhibition of Cholesterol Absorption in Rat Intestine with a Specific Cholesterol Esterase Inhibitor," FASEB Journal 6(4): PA1388 (1992).
Ganong, W.F., Review of Medical Physiology 249-250 (Lang Medical Publications, 1985)*
Gray, et al., "Primary structure of Mucor miehei aspartyl protease: evidence for a zymogen intermediate," Gene 48:41-53 (1987).
Griggs, et al., "Identification and Quantitation of Alditol Acetates of Neutral and Amino Sugars from Mucins by Automated Gas-Liquid Chromatography," Anal. Biochem. 43:369-381 (1971).
Hall and Muller, "Studies on the Bile Salt Stimulated Lipolytic Activity of Human Milk Using Whole Milk as Source of Both Substrate and Enzyme," Pediatr. Res. 16:251-255 (1982).
Hernell and Blackberg, "Bile-Salt-Stimulated Lipase of Human Milk and Lipid Digestion in the Neonatal Period," J. Pediatr. Gastro. and Nutri. 2(Suppl. 1):S242-S247 (1983).
Hewick, R.M., et al., "A Gas-Liquid Solid Phase Peptide and Protein Sequenator," J. Biol. Chem. 256:7990-7997 (1981).
Huang and Hui, "Metabolic fate of pancrease-derived cholesterol esterase in intestine: an in vitro study using Caco-2 cells," J. of Lipid Res. 31:2029 (1990).
Hui, D.Y., and J.A. Kissel, "Sequence identify between human pancreatic cholesterol esterase and bile salt-stimulated milk lipase," FEBS Lett. 276:131-134 (1990).
Innis, M.A., and D.H. Gelfand, in PCR Protocols. A Guide to Methods and Application 3-12, Innis, M.A., et al. (Eds.), Academic Press, New York, N.Y. (1990)*.
Jaenisch, R., "Transgenic Animals," Science 240:1468-1474 (1988).
Klag, M.J., et al., "Serum Cholesterol in Young Men and Subsequent Cardiovascular Disease," New Eng. J. Med., 328 (5), pp. 313-318 (Feb. 4, 1993).
Kraft, et al., "Using Mini-Prep Plasmid DNA for Sequencing Double Stranded Templates with Sequenase," BioTechniques 6:544-547 (1988).
Leary, W.e., "Survey Finds Major Gains in Cutting Blood Cholesterol," New York Times, section A, p. 18, col. 3 (Jun. 16, 1993).
Bierman, E.L., "Disorders of the Vascular System: Atherosclerosis and Other Forms of Arteriosclerosis," in Harrison's Principles of Internal Medicine 1014-1024, (E. Braunwald et al. 1987).
Bitter, G.A. et al., "Expression and Secretion Vectors for Yeast," Methods in Enzymology (Wu and Grossman, eds.) 153:516-544.
Bosner, et al., "Assessment of percent cholesterol absorption in humans with stable isotopes," J. of Lipid Res. 34:1047 (1993).
Bosner, et al., "Receptor-like function of heparin in the binding and uptate of neutal lipids," Proc. Natl. Acad. Sci. USA 85:7438-7442 (1988).
Bremel, R.D., Yom, H.C. and Bleck, G.T. J. Dairy Sci. 72:2826-2833 (1989)*
Brodt-Eppley and Hui, "Dietary regulation of cholesterol esterase mRNA level in rat pancreas," J. of Lipid Res. 35:27 (1994).
Brown, M.S., and J.L. Goldstein, "The Hyperlipoproteinemias and Other Disorders of Lipid Metabolism," in Harrison's Principles of Internal Medicine 1650-1661.
Clare, J.J. et al., "High-Level Expression of Tetanus Toxin Fragment in Pichia Pastoris Strains Containing Multiple Tanden Integrations of the Gene," Bio/Technology 9:455-460 (1991).
Clark, et al., "Inhibition of Hypercholesterolemia (Hyper C) by Specific Pancreatic Cholesterol Ester Hydrolase (PCEH) Inhibitors," FASEB J. 6"PA1388 (1992).
Cullen, D. et al., "Controlled Expression and Secretion of Bovine Chymosin in Aspergillus Nidulans," Bio/Technology 5:369-378 (1987).
Cullen, D., Gray, G.L., and Berka, R.M., Molecular Cloning Vectors for Aspergillus and Neurospora, in A Survey of Molecular Cloning Vectors and their Uses, (Butterworth Publishers, Stoneham, MA (1986)*
DiPersio, et al., "Purification of Pancreatic Cholesterol Esterase Expressed in Recombinant Baculovirus-Infected Sf9 Cells," Protein Expr. Purif. 3:114-120 (1992).
Downs, D. et al., "Proline-rich domain and glycosylation are not essential for the enzymic activity of bile salt-activated lipase. Kinae studies of a truncated form
Tang Jordan J. N.
Wang Chi-Sun
Lilling Herbert J.
Oklahoma Medical Research Foundation
LandOfFree
Method and compositions for reducing cholesterol absorption does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and compositions for reducing cholesterol absorption, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and compositions for reducing cholesterol absorption will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1607707